Diabetes Care Devices Market to 2018
Integrated Insulin Pumps with Continuous Glucose Monitoring Technology to
Add a New Dimension to Diabetes Management
GBI Research Report Guidance
GBI Research Report Guidance
· The report includes an executive summary capturing the key points that determine the dynamics of the
diabetes care devices market. Competition in the industry and key categories, segments and
geographical regions are also outlined.
· The ‘Market Characterization’ chapter provides information on the market size for the historic period
(2004-2011) and the forecast period (2011-2018). It also has information related to the diabetes care
devices market trends, market dynamics, and the competitive landscape. In the market dynamics
section, comprehensive information is provided on market drivers and restraints.
· The ‘Category Analysis and Forecasts’ chapter discusses glucose monitoring devices and insulin delivery
devices categories. Market size information for the historic period (2004-2011) and the forecast period
(2011-2018) is discussed for each category, along with market dynamics.
· This is followed by the ‘Country Analysis and Forecasts’ section. Market size information for the historic
period (2004-2011) and the forecast period (2011-2018) is provided for the US, Canada, the UK, France,
Germany, Italy, Spain, Japan, China, India, Australia and Brazil. A cross-country analysis of these
countries is also discussed.
· The ‘Competitive Assessment’ chapter gives profiles of the leading diabetes care device companies and
the companies’ key products.
· The ‘Pipeline Product Analysis’ chapter focuses on the pipeline products in various categories. Key
pipeline products are listed and discussed in detail, and product approval and expected launch dates
are also provided for a number of products.
· The ‘Consolidation Landscape’ chapter discusses the consolidation landscape in the diabetes care
devices industry. This chapter examines the total number of deals that took place during 2007-2012
(Q1, Q2).
© GBI Research. This is a licensed product and is not to be photocopied GBIME0071MR / Published AUG 2012
Page 2
Executive Summary
The global market for
Executive Summary
diabetes care devices is The Global Diabetes Care Devices Market is Forecast to Witness Moderate Growth During 2011−2018
forecast to reach $25.3
billion by 2018, with a CAGR The global market for diabetes care devices is forecast to reach $25.3 billion by 2018, with a Compound
of 5.2% from 2011 to 2018 Annual Growth Rate (CAGR) of 5.2% from 2011 to 2018. Glucose monitoring devices will be the largest
category in the market, with a value of $13.3 billion by 2018. The insulin delivery devices market was valued
at $8.1 billion in 2011, and is forecast to grow at a CAGR of 5.9% to reach revenues of $12 billion in 2018.
Diabetes Care Devices Market, Global, Overall Revenues ($bn), 2011−2018
30
25
CAGR (2011-2018): 5.2%
20
Revenue ($bn)
15
10
5
0
2011 2018
Source: GBI Research’s proprietary database [accessed on May 2, 2012]; primary research interviews with marketing managers and
other industry experts.
The market is primarily expected to be driven during the forecast period by the large patient pool suffering
from diabetes and the rapid uptake of innovative, minimally or non-invasive products. Examples include the
C8 MediSensors Optical Glucose Monitor, NBM-200G, Easy Check Breath Glucose and EyeSense Blood
Glucose Measurement Device, which utilize a patient’s sweat, exhaled breath or a fluorescent eye signal to
measure blood glucose levels. Integrated Continuous Glucose Monitoring (CGM) systems will also
contribute to the growth of the glucose monitoring devices market.
Compelling clinical needs, expanding research activities and applications to develop non-invasive therapies
will accelerate technological innovations in diabetes care devices. Moreover, increasing awareness,
improving diagnosis and treatment rates and a growing demand for safer, more effective, more accurate
and cost-effective therapies for diabetes will lead to increased adoption rates for diabetes care devices.
© GBI Research. This is a licensed product and is not to be photocopied GBIME0071MR / Published AUG 2012
Page 3
Executive Summary
F. Hoffmann-La Roche is the Dominant Player in the Global Diabetes Care Devices Market
In 2011, Roche, with a market share of 15.2%, was the leader in the global diabetes care devices market.
Diabetes Care Devices Market, Global, Key Company Share (%), 2011
F. Hoffmann-La R oc he
Ltd.
15.2%
Others
24.6%
LifeScan, Inc.
14.2%
Becton, Dickinson and
Company
4.2%
Abbott Laboratories
6.0% Medtronic, Inc.
7.5%
Bayer HealthCare AG
6.9%
Novo Nordisk A/S
Eli Lilly and Company 7.5%
6.9% Sanofi
7.0%
Source: GBI Research’s proprietary database [accessed on August 7, 2012]; primary research interviews with marketing managers and
other industry experts.
Roche’s Accu-Chek line of blood glucose monitoring devices and insulin delivery devices has driven the
growth of the company. Roche was followed by LifeScan and Medtronic, which had market shares of 14.2%
and 7.5% respectively. The OneTouch brand of blood glucose monitoring devices by Lifescan, and
Medtronic’s MiniMed line of insulin pumps, witnessed strong growth in 2011. Novo Nordisk, Sanofi and Eli
Lilly, which specialize in insulin delivery devices, had similar market shares of 7.5%, 7.0% and 6.9%
respectively. The launch of products that are innovative and technologically advanced will strengthen the
market position of these major players. The market share among the top players in the diabetes care
devices market is expected to be dynamic in the future, as Bayer HealthCare AG, with a market share of
6.9% of the total diabetes care devices market in 2011, is seeking to divest its blood glucose meters
business (Bayer via Reuters, 2012).
© GBI Research. This is a licensed product and is not to be photocopied GBIME0071MR / Published AUG 2012
Page 4
Executive Summary
The Global Diabetes Care Devices Pipeline is Dominated by Glucose Monitoring Devices
The current diabetes care
devices pipeline includes a The current diabetes care devices market scenario demands substantial output from the Research and
total of 187 pipeline Development (R&D) departments of medical device companies. The demand for innovative, non-invasive
products. The glucose and user-friendly diabetes care devices is on the rise. The current diabetes care devices pipeline includes a
monitoring devices category total of 187 pipeline products, of which the glucose monitoring devices category has the highest number of
has the highest number of products.
products
Diabetes Care Devices Market, Global, Pipeline Analysis, by Category (%), 2012
Other Diabetes Care
Devices
8%
Artific ial Panc reas
7%
Insulin Delivery Devices
25%
Glucose Monitoring
Devices
60%
Source: GBI Research’s proprietary database [accessed on May 10, 2012]; primary research interviews with marketing managers and
other industry experts.
The glucose monitoring devices category, with 113 pipeline products alone, accounts for 60% of the total
number of pipeline products, followed by the insulin delivery devices category with 46 pipeline products.
The artificial pancreas category has 13 products in the pipeline, and accounts for 7% of the total number of
pipeline products. The increasing demand for non-invasive devices is leading to the development of new
technologies such as measurement of blood glucose levels using occlusion spectroscopy, infrared
spectrometry and Raman spectroscopy, and insulin delivery using Intellispring technology and MEMS (Micro
Electro Mechanical Systems) chip technology. With the application of new technologies, these devices are
expected to be more accurate, more efficacious and more user-friendly compared to the currently
marketed products.
© GBI Research. This is a licensed product and is not to be photocopied GBIME0071MR / Published AUG 2012
Page 5
Table of Contents
1 Table of Contents
1 Table of Contents ........................................................................................................................................ 6
1.1 List of Tables .................................................................................................................................... 9
1.2 List of Figures................................................................................................................................. 11
2 Introduction .............................................................................................................................................. 12
3 Global Diabetes Care Devices Market - Overview ..................................................................................... 13
3.1 Disease Overview .......................................................................................................................... 13
3.1.1 Types of Diabetes .................................................................................................................. 13
3.1.2 Prevalence ............................................................................................................................. 13
3.1.3 Diabetes Care Devices ........................................................................................................... 13
4 Global Diabetes Care Devices Market - Market Characterization ............................................................. 14
4.1 Diabetes Care Devices Market, Global, Revenue ($bn), 2004-2011 .............................................. 14
4.2 Diabetes Care Devices Market, Global, Revenue ($bn), 2011-2018 .............................................. 15
4.3 Diabetes Care Devices Market, Global, Key Company Share (%), 2011......................................... 16
4.4 Global Diabetes Care Devices Market: Key Trends ........................................................................ 17
4.4.1 Increase in Healthcare Spending Attributable to Diabetes.................................................... 17
4.4.2 Increase in Awareness to Help Control Diabetes and Manage Complications ...................... 18
4.5 Global Diabetes Care Devices Market: Market Dynamics ............................................................. 19
4.5.1 Market Drivers ...................................................................................................................... 19
4.5.2 Market Restraints.................................................................................................................. 22
5 Global Diabetes Care Devices Market - Category Analysis ........................................................................ 24
5.1 Glucose Monitoring Devices Market, Global, Revenue ($m), 2004-2011...................................... 24
5.2 Glucose Monitoring Devices Market, Global, Revenue ($m), 2011-2018...................................... 25
5.3 Glucose Monitoring Devices Market, Global, Key Company Share (%), 2011 ............................... 27
5.4 Glucose Monitoring Devices Market: Market Dynamics ............................................................... 28
5.4.1 Market Drivers ...................................................................................................................... 28
5.4.2 Market Restraints.................................................................................................................. 31
5.5 Insulin Delivery Devices Market, Global, Revenue ($m), 2004-2011............................................. 32
5.6 Insulin Delivery Devices Market, Global, Revenue ($m), 2011-2018............................................. 33
5.7 Insulin Delivery Devices Market, Global, Key Company Share (%), 2011 ...................................... 34
5.8 Insulin Devices Market: Market Dynamics .................................................................................... 35
5.8.1 Market Drivers ...................................................................................................................... 35
5.8.2 Market Restraints.................................................................................................................. 36
6 Global Diabetes Care Devices Market - Country Analysis ......................................................................... 38
6.1 Global Diabetes Care Devices Market: Cross Country Analysis ..................................................... 38
6.2 Historic and Forecast Revenue, By Country .................................................................................. 39
6.2.1 Diabetes Care Devices Market, the US, Revenue ($m), 2004-2011 ....................................... 39
6.2.2 Diabetes Care Devices Market, the US, Revenue ($m), 2011-2018 ....................................... 40
6.2.3 Diabetes Care Devices Market, Canada, Revenue ($m), 2004-2011 ..................................... 41
6.2.4 Diabetes Care Devices Market, Canada, Revenue ($m), 2011-2018 ..................................... 42
6.2.5 Diabetes Care Devices Market, Germany, Revenue ($m), 2004-2011 ................................... 43
6.2.6 Diabetes Care Devices Market, Germany, Revenue ($m), 2011-2018 ................................... 44
6.2.7 Diabetes Care Devices Market, France, Revenue ($m), 2004-2011 ....................................... 45
6.2.8 Diabetes Care Devices Market, France, Revenue ($m), 2011-2018 ....................................... 46
6.2.9 Diabetes Care Devices Market, the UK, Revenue ($m), 2004-2011 ....................................... 47
6.2.10 Diabetes Care Devices Market, the UK, Revenue ($m), 2011-2018 ....................................... 48
6.2.11 Diabetes Care Devices Market, Italy, Revenue ($m), 2004-2011........................................... 49
6.2.12 Diabetes Care Devices Market, Italy, Revenue ($m), 2011-2018........................................... 50
6.2.13 Diabetes Care Devices Market, Spain, Revenue ($m), 2004-2011 ......................................... 51
6.2.14 Diabetes Care Devices Market, Spain, Revenue ($m), 2011-2018 ......................................... 52
6.2.15 Diabetes Care Devices Market, Australia, Revenue ($m), 2004-2011 ................................... 53
© GBI Research. This is a licensed product and is not to be photocopied GBIME0071MR / Published AUG 2012
Page 6
Table of Contents
6.2.16 Diabetes Care Devices Market, Australia, Revenue ($m), 2011-2018 ................................... 54
6.2.17 Diabetes Care Devices Market, Japan, Revenue ($m), 2004-2011 ........................................ 55
6.2.18 Diabetes Care Devices Market, Japan, Revenue ($m), 2011-2018 ........................................ 56
6.2.19 Diabetes Care Devices Market, China, Revenue ($m), 2004-2011......................................... 57
6.2.20 Diabetes Care Devices Market, China, Revenue ($m), 2011-2018......................................... 58
6.2.21 Diabetes Care Devices Market, India, Revenue ($m), 2004-2011.......................................... 59
6.2.22 Diabetes Care Devices Market, India, Revenue ($m), 2011-2018.......................................... 60
6.2.23 Diabetes Care Devices Market, Brazil, Revenue ($m), 2004-2011 ......................................... 61
6.2.24 Diabetes Care Devices Market, Brazil, Revenue ($m), 2011-2018 ......................................... 62
7 Global Diabetes Care Devices Market - Competitive Assessment............................................................. 63
7.1 F. Hoffmann-La Roche Ltd. ............................................................................................................ 63
7.1.1 Business Overview ................................................................................................................. 64
7.1.2 Key Marketed Products ......................................................................................................... 64
7.2 LifeScan, Inc. .................................................................................................................................. 64
7.2.1 Business Overview ................................................................................................................. 64
7.2.2 Key Marketed Products ......................................................................................................... 65
7.3 Medtronic, Inc. .............................................................................................................................. 65
7.3.1 Business Overview ................................................................................................................. 65
7.3.2 Key Marketed Products ......................................................................................................... 65
7.4 Novo Nordisk A/S .......................................................................................................................... 66
7.4.1 Business Overview ................................................................................................................. 66
7.4.2 Key Marketed Products ......................................................................................................... 66
7.5 Sanofi............................................................................................................................................. 67
7.5.1 Business Overview ................................................................................................................. 67
7.5.2 Key Marketed Products ......................................................................................................... 68
7.6 Eli Lilly and Company ..................................................................................................................... 68
7.6.1 Business Overview ................................................................................................................. 68
7.6.2 Key Marketed Products ......................................................................................................... 68
7.7 Bayer HealthCare AG ..................................................................................................................... 69
7.7.1 Business Overview ................................................................................................................. 69
7.7.2 Key Marketed Products ......................................................................................................... 69
7.8 Abbott Laboratories ...................................................................................................................... 69
7.8.1 Business Overview ................................................................................................................. 69
7.8.2 Key Marketed Products ......................................................................................................... 70
7.9 Becton, Dickinson and Company ................................................................................................... 70
7.9.1 Business Overview ................................................................................................................. 70
7.9.2 Key Marketed Products ......................................................................................................... 70
8 Global Diabetes Care Devices Market - Pipeline Analysis ......................................................................... 71
8.1 Glucose Monitoring Devices: Product Pipeline ............................................................................. 72
8.1.1 Glucose Monitoring Devices: List of Pipeline Products .......................................................... 72
8.1.2 Glucose Monitoring Devices: Profiles of Key Pipeline Products ............................................. 76
8.2 Insulin Delivery Devices: Product Pipeline..................................................................................... 82
8.2.1 Insulin Delivery Devices: List of Pipeline Products ................................................................. 82
8.2.2 Insulin Delivery Devices: Profiles of Key Pipeline Products .................................................... 84
8.3 Artificial Pancreas: Product Pipeline.............................................................................................. 90
8.3.1 Artificial Pancreas: List of Pipeline Products.......................................................................... 90
8.3.2 Artificial Pancreas: Profiles of Key Pipeline Products............................................................. 90
8.4 Other Diabetes Care Devices ......................................................................................................... 92
8.4.1 Other Diabetes Care Devices: List of Pipeline Products ......................................................... 92
9 Global Diabetes Care Devices Market - Consolidation Landscape ............................................................ 93
9.1 Key Deals: 2010-2012 (Q1, Q2)...................................................................................................... 93
9.1.1 EKF Diagnostics Holdings Sells International Brand Licensing AG ......................................... 93
© GBI Research. This is a licensed product and is not to be photocopied GBIME0071MR / Published AUG 2012
Page 7
Table of Contents
9.1.2 ActiveCare’s Acquisition of 4G Biometrics ............................................................................. 94
9.1.3 D. Medical Industries Completes Sale of its 57.5% Stake in NextGen Biomed ....................... 94
9.1.4 Insulet’s Acquisition of Neighborhood Diabetes .................................................................... 94
9.1.5 Roche Holding’s Acquisition of Medingo from Elron Electronic Industries ............................ 94
9.2 Key Partnership Deals: 2007-2012 (Q1, Q2) .................................................................................. 95
9.2.1 Insulet’s Agreement with Ypsomed Holding .......................................................................... 96
9.2.2 Haselmeier’s Distribution Agreement with Biocon ................................................................ 96
9.2.3 Roche Diagnostics’ Distribution Agreement with DexCom .................................................... 96
9.2.4 Cellnovo’s Technology Integration Agreement with LifeScan................................................ 96
9.2.5 Bayer HealthCare Diabetes Care’s Partnership with Medtronic ............................................ 96
9.2.6 PositiveID’s Agreement with HMD BioMedical ..................................................................... 97
9.2.7 Powder Pharma’s Agreement with Health-Chem Diagnostics .............................................. 97
9.2.8 Insulet’s Distribution Agreement with GlaxoSmithKline ........................................................ 97
9.2.9 Dance Pharma’s Licensing Agreement with Aerogen ............................................................ 97
9.2.10 EyeSense’s Agreement with Qiagen ...................................................................................... 97
9.2.11 AgaMatrix’s Agreement with Sanofi-Aventis ........................................................................ 97
9.2.12 JDRF’s Agreement with Becton, Dickinson and Company ..................................................... 98
9.2.13 Insulet’s Distribution Agreement with Ypsomed Holding ...................................................... 98
9.2.14 Luminous Medical’s Agreement with a Supplier of Electrochemical Sensors ........................ 98
9.2.15 Arkray’s Distribution Agreement with Nipro Corporation ..................................................... 98
9.2.16 Edwards Lifesciences’ Agreement with DexCom ................................................................... 98
9.2.17 Oxygen Biotherapeutics’ Agreement with Glucometrics ....................................................... 99
9.2.18 Smiths Medical’s Agreement with Abbott Labs ..................................................................... 99
9.2.19 Mankind Pharma’s Agreement with Roche Diagnostics........................................................ 99
9.2.20 DexCom’s Joint Venture with Animas .................................................................................... 99
9.2.21 Insulet Corporation’s Partnership with DexCom.................................................................... 99
9.2.22 BioPharmetics’ Agreement with HMD Biomedical .............................................................. 100
10 Appendix ................................................................................................................................................. 101
10.1 Definitions ................................................................................................................................... 101
10.1.1 Diabetes Care Devices ......................................................................................................... 101
10.1.2 Glucose Monitoring Devices ................................................................................................ 101
10.1.3 Insulin Delivery Devices ....................................................................................................... 101
10.2 Acronyms..................................................................................................................................... 102
10.3 Sources ........................................................................................................................................ 104
10.4 Research Methodology ............................................................................................................... 105
10.4.1 Secondary Research ............................................................................................................ 105
10.4.2 Primary Research ................................................................................................................ 105
10.4.3 Models................................................................................................................................. 106
10.4.4 Forecasts ............................................................................................................................. 106
10.4.5 Expert Panels ....................................................................................................................... 106
10.5 Contact Us ................................................................................................................................... 106
10.6 Disclaimer .................................................................................................................................... 107
© GBI Research. This is a licensed product and is not to be photocopied GBIME0071MR / Published AUG 2012
Page 8
Table of Contents
1.1 List of Tables
Table 1: Diabetes Care Devices Market, Global, Revenue ($bn), 2004-2011 ............................................. 14
Table 2: Diabetes Care Devices Market, Global, Revenue ($bn), 2011-2018 ............................................. 15
Table 3: Diabetes Care Devices Market, Global, Key Company Revenue ($m), 2011 ................................ 16
Table 4: Glucose Monitoring Devices Market, Global, Revenue ($m), 2004-2011..................................... 24
Table 5: Glucose Monitoring Devices Market, Global, Revenue ($m), 2011-2018..................................... 25
Table 6: Glucose Monitoring Devices Market, Global, Key Company Revenue ($m), 2011 ....................... 27
Table 7: Glucose Monitoring Devices Market, Global, Key Product Launches, 2011−2012 ....................... 28
Table 8: Insulin Delivery Devices Market, Global, Revenue ($m), 2004-2011 ............................................ 32
Table 9: Insulin Delivery Devices Market, Global, Revenue ($m), 2011-2018 ............................................ 33
Table 10: Insulin Delivery Devices Market, Global, Key Company Revenue ($m), 2011 .............................. 34
Table 11: Diabetes Care Devices Market, Cross Country Analysis, Global, CAGR, 2004-2018 ..................... 38
Table 12: Diabetes Care Devices Market, the US, Revenue ($m), 2004-2011 .............................................. 39
Table 13: Diabetes Care Devices Market, the US, Revenue ($m), 2011-2018 .............................................. 40
Table 14: Diabetes Care Devices Market, Canada, Revenue ($m), 2004-2011 ............................................ 41
Table 15: Diabetes Care Devices Market, Canada, Revenue ($m), 2011-2018 ............................................ 42
Table 16: Diabetes Care Devices Market, Germany, Revenue ($m), 2004-2011.......................................... 43
Table 17: Diabetes Care Devices Market, Germany, Revenue ($m), 2011-2018.......................................... 44
Table 18: Diabetes Care Devices Market, France, Revenue ($m), 2004-2011 ............................................. 45
Table 19: Diabetes Care Devices Market, France, Revenue ($m), 2011-2018 ............................................. 46
Table 20: Diabetes Care Devices Market, the UK, Revenue ($m), 2004-2011 ............................................. 47
Table 21: Diabetes Care Devices Market, the UK, Revenue ($m), 2011-2018 ............................................. 48
Table 22: Diabetes Care Devices Market, Italy, Revenue ($m), 2004-2011 ................................................. 49
Table 23: Diabetes Care Devices Market, Italy, Revenue ($m), 2011-2018 ................................................. 50
Table 24: Diabetes Care Devices Market, Spain, Revenue ($m), 2004-2011................................................ 51
Table 25: Diabetes Care Devices Market, Spain, Revenue ($m), 2011-2018................................................ 52
Table 26: Diabetes Care Devices Market, Australia, Revenue ($m), 2004-2011 .......................................... 53
Table 27: Diabetes Care Devices Market, Australia, Revenue ($m), 2011-2018 .......................................... 54
Table 28: Diabetes Care Devices Market, Japan, Revenue ($m), 2004-2011 ............................................... 55
Table 29: Diabetes Care Devices Market, Japan, Revenue ($m), 2011-2018 ............................................... 56
Table 30: Diabetes Care Devices Market, China, Revenue ($m), 2004-2011 ............................................... 57
Table 31: Diabetes Care Devices Market, China, Revenue ($m), 2011-2018 ............................................... 58
Table 32: Diabetes Care Devices Market, India, Revenue ($m), 2004-2011 ................................................ 59
Table 33: Diabetes Care Devices Market, India, Revenue ($m), 2011-2018 ................................................ 60
Table 34: Diabetes Care Devices Market, Brazil, Revenue ($m), 2004-2011................................................ 61
Table 35: Diabetes Care Devices Market, Brazil, Revenue ($m), 2011-2018................................................ 62
Table 36: Diabetes Care Devices Market, Global, Pipeline Analysis, by Category, 2012 .............................. 71
Table 37: Diabetes Care Devices Market, Glucose Monitoring Devices, Global, List of Pipeline Products,
Table 1, 2012 ................................................................................................................................ 72
Table 38: Diabetes Care Devices Market, Glucose Monitoring Devices, Global, List of Pipeline Products,
Table 2, 2012 ................................................................................................................................ 73
Table 39: Diabetes Care Devices Market, Glucose Monitoring Devices, Global, List of Pipeline Products,
Table 3, 2012 ................................................................................................................................ 74
Table 40: Diabetes Care Devices Market, Glucose Monitoring Devices, Global, List of Pipeline Products,
Table 4, 2012 ................................................................................................................................ 75
Table 41: Diabetes Care Devices Market, Pipeline Analysis - Enlite Sensor, 2012 ....................................... 76
Table 42: Diabetes Care Devices Market, Pipeline Analysis - C8 MediSensors Optical Glucose Monitor,
2012.............................................................................................................................................. 77
Table 43: Diabetes Care Devices Market, Pipeline Analysis - GlucoTrack, 2012 .......................................... 77
Table 44: Diabetes Care Devices Market, Pipeline Analysis - Integrated Guardian Real-Time Continuous
Glucose Monitoring System, 2012................................................................................................ 78
Table 45: Diabetes Care Devices Market, Pipeline Analysis - NBM- 200G, 2012 ......................................... 78
Table 46: Diabetes Care Devices Market, Pipeline Analysis - OptiScannner, 2012 ...................................... 79
Table 47: Diabetes Care Devices Market, Pipeline Analysis - Animas Vibe Insulin Pump and CGM System,
2012.............................................................................................................................................. 79
Table 48: Diabetes Care Devices Market, Pipeline Analysis - Easy Check Breath Glucose Detection System,
2012.............................................................................................................................................. 80
© GBI Research. This is a licensed product and is not to be photocopied GBIME0071MR / Published AUG 2012
Page 9
Table of Contents
Table 49: Diabetes Care Devices Market, Pipeline Analysis - EyeSense Blood Glucose Measurement Device,
2012.............................................................................................................................................. 80
Table 50: Diabetes Care Devices Market, Pipeline Analysis - Redscan, 2012 ............................................... 81
Table 51: Diabetes Care Devices Market, Pipeline Analysis - 5th Generation Short-term Sensor, 2012 ..... 81
Table 52: Diabetes Care Devices Market, Insulin Delivery Devices, Global, List of Pipeline Products, Table 1,
2012.............................................................................................................................................. 82
Table 53: Diabetes Care Devices Market, Insulin Delivery Devices, Global, List of Pipeline Products, Table 2,
2012.............................................................................................................................................. 83
Table 54: Diabetes Care Devices Market, Pipeline Analysis - Paradigm Veo System, 2012 ......................... 84
Table 55: Diabetes Care Devices Market, Pipeline Analysis - ClikSTAR, 2012 .............................................. 84
Table 56: Diabetes Care Devices Market, Pipeline Analysis - NovoPen Echo, 2012 ..................................... 85
Table 57: Diabetes Care Devices Market, Pipeline Analysis - Next Generation OneTouch Ping, 2012 ........ 85
Table 58: Diabetes Care Devices Market, Pipeline Analysis - Eros Insulin Pump, 2012................................ 86
Table 59: Diabetes Care Devices Market, Pipeline Analysis - Needle-Free Injection Device, 2012 .............. 86
Table 60: Diabetes Care Devices Market, Pipeline Analysis - Spring Zone Insulin Delivery System, 2012 ... 87
Table 61: Diabetes Care Devices Market, Pipeline Analysis - Solo MicroPump Insulin Delivery System, 2012
...................................................................................................................................................... 87
Table 62: Diabetes Care Devices Market, Pipeline Analysis - PaQ Insulin Delivery Device, 2012 ................ 88
Table 63: Diabetes Care Devices Market, Pipeline Analysis - Jewel Pump, 2012 ......................................... 89
Table 64: Diabetes Care Devices Market, Pipeline Analysis - Cellnovo Wireless Insulin Pump System, 2012
...................................................................................................................................................... 89
Table 65: Diabetes Care Devices Market, Artificial Pancreas, Global, List of Pipeline Products, 2012......... 90
Table 66: Diabetes Care Devices Market, Pipeline Analysis - Artificial Pancreas, 2012 ............................... 90
Table 67: Diabetes Care Devices Market, Pipeline Analysis - Bionic Pancreas, 2012 ................................... 91
Table 68: Diabetes Care Devices Market, Pipeline Analysis - Closed-Loop Artificial Pancreas System, 2012
...................................................................................................................................................... 91
Table 69: Diabetes Care Devices Market, Pipeline Analysis - MiniMed Closed Loop Insulin Delivery System,
2012.............................................................................................................................................. 91
Table 70: Diabetes Care Devices Market, Other Diabetes Care Devices, Global, List of Pipeline Products,
2012.............................................................................................................................................. 92
Table 71: Diabetes Care Devices Market, Global, Key Deals, 2010-2012 (Q1, Q2) ...................................... 93
Table 72: Diabetes Devices Market, Global, Key Partnerships, 2007-2012 (Q1, Q2) ................................... 95
© GBI Research. This is a licensed product and is not to be photocopied GBIME0071MR / Published AUG 2012
Page 10
Table of Contents
1.2 List of Figures
Figure 1: Diabetes Care Devices Market, Global, Revenue ($bn), 2004-2011 ............................................. 14
Figure 2: Diabetes Care Devices Market, Global, Revenue ($bn), 2011-2018 ............................................. 15
Figure 3: Diabetes Care Devices Market, Global, Key Company Share (%), 2011 ....................................... 16
Figure 4: Diabetes Care Devices Market, Global, Healthcare Expenditure ($bn), by Country, 2010−2030 . 17
Figure 5: Diabetes Care Devices Market, Global, Number of People with Diabetes (20-79 years), by
Country, 2011−2030 ..................................................................................................................... 20
Figure 6: Glucose Monitoring Devices Market, Global, Revenue ($m), 2004-2011..................................... 24
Figure 7: Glucose Monitoring Devices Market, Global, Revenue ($m), 2011-2018..................................... 25
Figure 8: Glucose Monitoring Devices Market, Global, Key Company Share (%), 2011 ......